Cargando…
Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies
Protein misfolding is a general hallmark of protein deposition diseases, such as Alzheimer’s disease or Parkinson’s disease, in which different types of aggregated species (oligomers, protofibrils and fibrils) are generated by the cells. Despite widespread interest, the relationship between oligomer...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897347/ https://www.ncbi.nlm.nih.gov/pubmed/35244787 http://dx.doi.org/10.1007/s00018-022-04166-9 |
_version_ | 1784663381416869888 |
---|---|
author | Cascella, Roberta Bigi, Alessandra Cremades, Nunilo Cecchi, Cristina |
author_facet | Cascella, Roberta Bigi, Alessandra Cremades, Nunilo Cecchi, Cristina |
author_sort | Cascella, Roberta |
collection | PubMed |
description | Protein misfolding is a general hallmark of protein deposition diseases, such as Alzheimer’s disease or Parkinson’s disease, in which different types of aggregated species (oligomers, protofibrils and fibrils) are generated by the cells. Despite widespread interest, the relationship between oligomers and fibrils in the aggregation process and spreading remains elusive. A large variety of experimental evidences supported the idea that soluble oligomeric species of different proteins might be more toxic than the larger fibrillar forms. Furthermore, the lack of correlation between the presence of the typical pathological inclusions and disease sustained this debate. However, recent data show that the β-sheet core of the α-Synuclein (αSyn) fibrils is unable to establish persistent interactions with the lipid bilayers, but they can release oligomeric species responsible for an immediate dysfunction of the recipient neurons. Reversibly, such oligomeric species could also contribute to pathogenesis via neuron-to-neuron spreading by their direct cell-to-cell transfer or by generating new fibrils, following their neuronal uptake. In this Review, we discuss the various mechanisms of cellular dysfunction caused by αSyn, including oligomer toxicity, fibril toxicity and fibril spreading. |
format | Online Article Text |
id | pubmed-8897347 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-88973472022-03-08 Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies Cascella, Roberta Bigi, Alessandra Cremades, Nunilo Cecchi, Cristina Cell Mol Life Sci Review Protein misfolding is a general hallmark of protein deposition diseases, such as Alzheimer’s disease or Parkinson’s disease, in which different types of aggregated species (oligomers, protofibrils and fibrils) are generated by the cells. Despite widespread interest, the relationship between oligomers and fibrils in the aggregation process and spreading remains elusive. A large variety of experimental evidences supported the idea that soluble oligomeric species of different proteins might be more toxic than the larger fibrillar forms. Furthermore, the lack of correlation between the presence of the typical pathological inclusions and disease sustained this debate. However, recent data show that the β-sheet core of the α-Synuclein (αSyn) fibrils is unable to establish persistent interactions with the lipid bilayers, but they can release oligomeric species responsible for an immediate dysfunction of the recipient neurons. Reversibly, such oligomeric species could also contribute to pathogenesis via neuron-to-neuron spreading by their direct cell-to-cell transfer or by generating new fibrils, following their neuronal uptake. In this Review, we discuss the various mechanisms of cellular dysfunction caused by αSyn, including oligomer toxicity, fibril toxicity and fibril spreading. Springer International Publishing 2022-03-04 2022 /pmc/articles/PMC8897347/ /pubmed/35244787 http://dx.doi.org/10.1007/s00018-022-04166-9 Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Cascella, Roberta Bigi, Alessandra Cremades, Nunilo Cecchi, Cristina Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies |
title | Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies |
title_full | Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies |
title_fullStr | Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies |
title_full_unstemmed | Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies |
title_short | Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies |
title_sort | effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897347/ https://www.ncbi.nlm.nih.gov/pubmed/35244787 http://dx.doi.org/10.1007/s00018-022-04166-9 |
work_keys_str_mv | AT cascellaroberta effectsofoligomertoxicityfibriltoxicityandfibrilspreadinginsynucleinopathies AT bigialessandra effectsofoligomertoxicityfibriltoxicityandfibrilspreadinginsynucleinopathies AT cremadesnunilo effectsofoligomertoxicityfibriltoxicityandfibrilspreadinginsynucleinopathies AT cecchicristina effectsofoligomertoxicityfibriltoxicityandfibrilspreadinginsynucleinopathies |